> top > docs > PMC:7650537 > spans > 13651-14640 > annotations

PMC:7650537 / 13651-14640 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T100 119-122 Body_part denotes IgG http://purl.org/sig/ont/fma/fma62872
T101 132-140 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T102 448-453 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T103 575-578 Body_part denotes IgG http://purl.org/sig/ont/fma/fma62872

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T9 448-453 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T66 62-70 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T67 73-82 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T68 108-116 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T69 256-264 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T70 564-572 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T71 868-876 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T126 46-47 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T127 427-429 http://purl.obolibrary.org/obo/CLO_0001302 denotes 34
T128 510-513 http://purl.obolibrary.org/obo/CLO_0050884 denotes ten
T129 525-526 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T130 544-550 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T131 648-649 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T132 766-771 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T133 809-810 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T134 843-845 http://purl.obolibrary.org/obo/CLO_0050050 denotes S1

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T105 0-148 Sentence denotes Thirty-seven samples taken from patients with a PCR-confirmed SARS-CoV-2 infection were analyzed with eight SARS-CoV-2 IgG or total antibody assays.
T106 149-292 Sentence denotes Samples #1, #7, and #9 were taken nine days before to four days after PCR and were all found to be free of SARS-CoV-2 antibodies by the assays.
T107 293-405 Sentence denotes These samples were not considered for calculation of the sensitivity but demonstrated seroconversion (Figure 1).
T108 406-506 Sentence denotes Out of the remaining 34 samples, only one serum (#20; Figure 1), which was obtained from patient no.
T109 507-616 Sentence denotes 12 ten days after a positive RT-PCR, tested negative for SARS-CoV-2 IgG/total antibodies in the eight assays.
T110 617-665 Sentence denotes However, this sample exhibited a PRNT 1:10–1:20.
T111 666-731 Sentence denotes All other samples were reactive in at least one assay (Figure 1).
T112 732-847 Sentence denotes Twenty (76.9%) patients developed virus-neutralizing antibodies, as shown by a PRNT >1:10 (Figure 1 and Figure S1).
T113 848-989 Sentence denotes With respect to the SARS-CoV-2 PCR (reference 1) or the PRNT results (reference 2), assay sensitivities ranged from 80.8% to 96.3% (Table 1).

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
254 32-40 Species denotes patients Tax:9606
255 495-502 Species denotes patient Tax:9606
256 747-755 Species denotes patients Tax:9606
257 868-878 Species denotes SARS-CoV-2 Tax:2697049
258 108-118 Species denotes SARS-CoV-2 Tax:2697049
259 256-266 Species denotes SARS-CoV-2 Tax:2697049
260 564-574 Species denotes SARS-CoV-2 Tax:2697049
261 62-82 Disease denotes SARS-CoV-2 infection MESH:C000657245